Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Hoofdauteurs: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
Formaat: | Journal article |
Gepubliceerd in: |
American Society for Clinical Investigation
2019
|
Gelijkaardige items
-
Diagnostic use of autoantibodies in myasthenia gravis.
door: Leite, M, et al.
Gepubliceerd in: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
door: Miriam L. Fichtner, et al.
Gepubliceerd in: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
door: Gomez, A, et al.
Gepubliceerd in: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
door: Miriam L Fichtner, et al.
Gepubliceerd in: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
door: Miriam L. Fichtner, et al.
Gepubliceerd in: (2022-01-01)